De Novo device
Oxiplex
Fziomed, Inc. · Absorbable Gel For Intraoperative Use In Spine Surgery (QVL, Class II) · First FDA decision Jun 17, 2025, newest May 1, 2026Degenerative disc disease and spinal stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
De Novo pathway
Device trials
2
Naming "Oxiplex"
MAUDE reports
0
Brand "Oxiplex", since 2015
PubMed studies
23
Mentioning "Oxiplex"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Oxiplex
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Oxiplex510(k)
K253326 · Decided May 1, 2026 · 213 days after receipt
Device type: Absorbable Gel For Intraoperative Use In Spine Surgery (QVL) · Orthopedic Surgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Oxiplex", any status and sponsor, newest update first.
Raydiant Oximetry, Inc.Not on our public-company list
NCT06405984 · 35 participants · Start Apr 15, 2024 · Primary completion Oct 17, 2025
Device: Fetal Oxygenation Measurements · For: Fetal Hypoxia; Fetal Distress; Fetal Conditions and 4 more
Sites: Norfolk, Virginia
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Oxiplex", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QVL
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Oxiplex"[tiab]. The summary above synthesizes these.
- Comparison of Oxiplex and Gore-Tex effectivity in an experimental peridural fibrosis model.
Kurt G, Cemil B, Celik B, et al. · Neurocirugia (Astur) · 2009Comparative Study, Evaluation Study
- Oxiplex reduces leg pain, back pain, and associated symptoms after lumbar discectomy.
Rhyne AL, Blumenthal SL, Frank EH, et al. · Spine (Phila Pa 1976) · 2012Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Intercoat (Oxiplex/AP gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study.
Fuchs N, Smorgick N, Ben Ami I, et al. · J Minim Invasive Gynecol · 2014Randomized Controlled Trial
- The Oxiplex/SP gel-morphine compound after lumbar microdiscectomy in the management of postoperative pain. Report of 20 cases.
Mastronardi L, Pappagallo M, Tatta C · Surg Neurol · 2005Comparative Study
- A review of techniques for adhesion prevention after gynaecological surgery.
Metwally M, Cheong Y, Li TC · Curr Opin Obstet Gynecol · 2008Review
- Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel: a pilot study.
Young P, Johns A, Templeman C, et al. · Fertil Steril · 2005Comparative Study, Multicenter Study
- Reduction of Leg Pain by Oxiplex Gel After Lumbar Discectomy in Patients With Predominant Leg Pain and Elevated Levels of Lower Back Pain: A Prospective, Randomized, Blinded, Multicenter Clinical Study.
Lei W, Ehmsen RJ, Chiacchierini RP, et al. · J Spinal Disord Tech · 2015Multicenter Study, Randomized Controlled Trial
- Reduction of leg pain and lower-extremity weakness for 1 year with Oxiplex/SP gel following laminectomy, laminotomy, and discectomy.
Kim KD, Wang JC, Robertson DP, et al. · Neurosurg Focus · 2004Clinical Trial, Comparative Study
- Reduction of radiculopathy and pain with Oxiplex/SP gel after laminectomy, laminotomy, and discectomy: a pilot clinical study.
Kim KD, Wang JC, Robertson DP, et al. · Spine (Phila Pa 1976) · 2003Clinical Trial, Multicenter Study
- Surgical measures for endometriosis-related infertility: a plea for research.
Somigliana E, Benaglia L, Vigano' P, et al. · Placenta · 2011Review
- Effect of oxiplex* films (PEO/CMC) on adhesion formation and reformation in rabbit models and on peritoneal infection in a rat model.
Rodgers KE, Schwartz HE, Roda N, et al. · Fertil Steril · 2000Research Support, Non-U.S. Gov't
- Reduced in vivo skeletal muscle oxygen consumption in patients with chronic heart failure--a study using Near Infrared Spectrophotometry (NIRS).
Abozguia K, Phan TT, Shivu GN, et al. · Eur J Heart Fail · 2008Research Support, Non-U.S. Gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.